Rex Allosteric Biosensor for NADH/NAD+ Ratio Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring the NADH/NAD+ ratio in bacteria are low-throughput, inaccurate, and cumbersome, suffering from poor signal-to-noise ratios and instability of NADH during sample preparation, limiting the study of redox imbalances and metabolic engineering.
Innovation Solution
A genetically-encoded redox biosensor system based on the Rex allosteric transcription factor, which regulates gene expression in response to NAD(H) levels, allowing for proportional measurement of the NADH/NAD+ ratio using a dual-plasmid system with a constitutive promoter and a reporter protein, functional under various conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods (NADH auto-fluorescence, enzymatic assays, LC-MS) are used to measure NADH/NAD+ ratio, then measurement can be performed, but the signal-to-noise ratio is poor and the measurement accuracy is low due to high background auto-fluorescence and NADH instability
Solution Approach 1:
The patent uses an allosteric transcription factor (Rex) as an intermediary that binds to NAD(H) and undergoes a conformational change. This conformational change is then coupled to a fluorescent reporter protein, allowing indirect measurement of NADH/NAD+ ratio while avoiding direct detection of NADH's weak auto-fluorescence signal. The intermediary converts the chemical binding event into a measurable optical signal with high contrast.
Solution Approach 2:
The patent replaces traditional biochemical measurement methods (enzymatic assays, LC-MS) with a genetically-encoded optical biosensor system. The mechanical/biochemical interaction between Rex and NAD(H) is transduced into an optical signal through conformational coupling with a fluorescent protein, enabling non-invasive, real-time measurement without sample preparation that causes NADH instability.
2Productivity
If traditional measurement methods are used, then NADH/NAD+ ratio can be determined, but the process is low-throughput and cumbersome, limiting the study of redox imbalances
Solution Approach 1:
The biosensor system is self-reporting within the cell. Each cell expressing the Rex-fluorescent protein fusion automatically generates its own measurement signal based on its internal NADH/NAD+ ratio, eliminating the need for external sample collection, preparation, and analysis. This enables high-throughput screening of thousands of cells or mutants simultaneously using flow cytometry or plate readers.
Solution Approach 2:
The patent changes the measurement parameter from direct NADH concentration detection to ratio-dependent fluorescent signal intensity. By designing the biosensor response to depend on the NADH/NAD+ ratio rather than absolute NADH levels, the system achieves robustness against variations in cellular metabolism and enables high-throughput comparison across different conditions without time-consuming calibration for each sample.
3Productivity
If genetically-encoded biosensors are used for high-throughput screening, then throughput is improved, but measurement precision and dynamic range are limited compared to traditional methods
Solution Approach 1:
The patent exploits the dynamic conformational change of the allosteric transcription factor Rex upon NAD(H) binding. This dynamic structural transition is coupled to the fluorescent reporter, creating a biosensor with high dynamic range that can distinguish subtle changes in NADH/NAD+ ratio. The dynamic nature of the conformational change allows the sensor to respond rapidly and proportionally to ratio changes, achieving both high throughput and high precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput screening and accurate measurement of NADH/NAD+ ratios, facilitating the understanding of redox imbalances and metabolic engineering, particularly in E. coli, with enhanced dynamic range and signal intensity, suitable for aerobic and anaerobic conditions.
Implementation Method 1
Rex is an allosteric transcription factor that regulates gene expression by binding to NAD(H)
Implementation Method 2
upon binding to a target metabolite, undergoes chemical, conformational or regulatory change coupled to a spectroscopic response
Implementation Method 3
undergoes chemical, conformational or regulatory change coupled to a spectroscopic response
Data Source
AI summary
Described herein is a redox biosensor system for measurement of NADH/NAD+ ratio including a host strain or cell-free system including first and a second expression cassette; the first expression cassette including, in operable communication, a constitutive promoter and a gene encoding a Rex allosteric transcription factor that regulates gene expression by binding to NAD(H); and the second expression cassette including, in operable communication, a promoter regulated by the Rex allosteric transcription factor, and a gene encoding a reporter protein, wherein the first expression cassette expresses the Rex allosteric transcription factor, and, in the presence of NAD(H), the Rex allosteric transcription factor drives expression of the reporter protein from the second expression cassette, and wherein the expression of the reporter protein is proportional to the NADH/NAD+ ratio.